Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Lipid peroxides in obese patients and effects of weight loss with orlistat on lipid peroxides levels

International Journal of Obesity volume 29, pages 142–145 (2005)Cite this article

Abstract

OBJECTIVE:

Obesity is a well-known risk factor of atherosclerosis. Recent studies showed that obesity is associated with enhanced lipid peroxidation. The aim of this study is to investigate the effect of weight reduction with orlistat treatment on lipid peroxidation levels. We assessed lipid peroxidation by measuring the concentration of plasma malondialdehyde (MDA).

DESIGN:

A randomized, controlled, open-label 6-month study.

SUBJECTS:

In total, 36 obese (body mass index (BMI) >30 kg/m2) and 11 healthy age-matched control subjects were enrolled in the study.

MEASUREMENTS:

Fasting glucose, triglyceride, total cholesterol, HDL cholesterol and LDL cholesterol and MDA levels were measured in both groups. Obese subjects received orlistat, 120 mg three times daily together with hypocaloric diet. After 6 months of treatment laboratory tests were repeated.

RESULTS:

MDA levels were significantly higher in obese patients than the control group (P<0.0001). After 6 months of treatment in obese subjects, the mean weight of the patients decreased by 6.8 kg, the BMI by 3.2 kg/m2. Plasma MDA levels were significantly reduced by weight loss from 2±0.77 to 0.89±0.41 nmol/ml (P<0.001). BMI correlated with MDA levels at baseline (r=0.6, P<0.0001). Changes in BMI was positively associated with plasma MDA level reduction (r=0.36, P<0.05).

CONCLUSION:

These results indicate that obesity is associated with increases in endogenous lipid peroxides. Our data show that the indicator of lipid peroxidation—MDA—falls markedly in association with weight loss with orlistat. The demonstration of decreased free radical generation has important implications for oxidative mechanism underlying obesity-associated disorders.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Hubert HB, Feinleib M, McNamara PM, Castelli WP . Obesity as an independent risk factor for cardiovascular disease: a 26 year follow-up participants in the Framingham Heart Study. Circulation 1983; 67: 968–977.

    Article  CAS  Google Scholar 

  2. Garrison RJ, Higgins MW, Kannel WB . Obesity and coronary heart disease. Curr Opin Lipidol 1996; 7: 199–202.

    Article  CAS  Google Scholar 

  3. Kaplan NM . The deadly quartet. Upper body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med 1989; 149: 1514–1520.

    Article  CAS  Google Scholar 

  4. Denke MA, Sempos CT, Grundy SM . Excess body weight: an under-recognized contributor to dyslipidemia in white American women. Arch Intern Med 1994; 154: 401–410.

    Article  CAS  Google Scholar 

  5. Witztum JL . The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793–795.

    Article  CAS  Google Scholar 

  6. Steinberg D, Lewis A . Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation 1997; 95: 1062–1071.

    Article  CAS  Google Scholar 

  7. Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P . Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem 1997; 43: 1209–1214.

    CAS  PubMed  Google Scholar 

  8. Davi G, Guagnano MT, Ciabattoni G, Basili S, Falco A, Marinopiccoli M . Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 2002; 288: 2008–2014.

    Article  CAS  Google Scholar 

  9. Olusi SO . Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int J Obes Relat Metab Disord 2002; 26: 1159–1164.

    Article  CAS  Google Scholar 

  10. Glazer G . Long-term pharmacotherapy obesity 2000. Arch Intern Med 2001; 161: 1814–1824.

    Article  CAS  Google Scholar 

  11. Lindgarde F . The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study. J Intern Med 2000; 248: 245–254.

    Article  CAS  Google Scholar 

  12. Davidson MH, Hauptman J, DiGirolamo M, Foreyt JP, Halsted CH, Heber D, Heimburger DC, Lucas CP, Robbins DC, Chung J, Heymsfield SB . Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA 1999; 281: 235–241.

    Article  CAS  Google Scholar 

  13. Friedewald WT, Levy RI, Fredericksen DS . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.

    CAS  Google Scholar 

  14. Young IS, Trimble ER . Measurement of malondialdeyhde in plasma by high-performance liquid choromatography with fluorimetric detection. Ann Clin Biochem 1991; 28: 504–508.

    Article  Google Scholar 

  15. Prazny M, Skrha J, Hilgertova J . Plasma malondialdehyde and obesity: is there a relationship? Clin Chem Lab Med 1999; 37: 1129–1130.

    Article  CAS  Google Scholar 

  16. Mutlu-Turkoglu U, Oztezcan S, Telci A, Orhan Y, Aykac-Toker G, Sivas A, Uysal M . An increase in lipoprotein oxidation and endogenous lipid peroxides in serum of obese women. Clin Exp Med 2003; 2: 171–174.

    Article  CAS  Google Scholar 

  17. Van Gaal LF, Vertommen J, De Leeuw IH . The in vitro oxidizability of lipoprotein particles in obese and non-obese subjects. Atherosclerosis 1998; 137: 39–44.

    Article  Google Scholar 

  18. Stmoneau JA, Colberg SR, Thate FL, Kelley DE . Skeletal muscle glycolitic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. FASEB J 1995; 9: 273–278.

    Article  Google Scholar 

  19. Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T . Tumor necrosis factor-α in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab 1998; 83: 2907–2910.

    CAS  PubMed  Google Scholar 

  20. Sidoti-de Fraisse C, Rincheval V, Risler Y, Mignotte B, Vayssiere JL . TNF-α activates at least two apoptotic signaling cascades. Oncogene 1998; 17: 1639–1651.

    Article  CAS  Google Scholar 

  21. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C . Prospective study of intentional weight loss and mortality in overweight white men aged 40–64 years. Am J Epidemiol 1999; 149: 491–503.

    Article  CAS  Google Scholar 

  22. Vasankari T, Fogelholm M, Kukkonen-Harjula K, Nenonen A, Kujala U, Oja P, Vuori I, Pasanen P, Neuvonen K, Ahotupa M . Reduced oxidized low-density lipoprotein after weight reduction in obese premenopausal women. Int J Obesity 2001; 25: 205–211.

    Article  CAS  Google Scholar 

  23. Samuelsson L, Gottsater A, Lindgarde F . Decreasing levels of tumour necrosis factor α and interleukin 6 during lowering of body mass index with orlistat or placebo in obese subjects with cardiovascular risk factors. Diabetes Obes Metab 2003; 5: 195–201.

    Article  CAS  Google Scholar 

  24. Kisakol G, Guney E, Bayraktar F, Yilmaz C, Kabalak T, Ozmen D . Effect of surgical weight loss on free radical and antioxidant balance: a preliminary report. Obes Surg 2002; 12: 795–800.

    Article  Google Scholar 

  25. Dandone P, Mohanty P, Ghanim H, Aljada A, Browne R, Hamouda W, Prabhala A, Afzal A, Garg R . The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes lipid peroxidation and protein carbonylation. J Clin Endocrinol Metab 2001; 86: 355–362.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiology Department, Uludag University Medical School, Bursa, Turkey

    D Yesilbursa, A Serdar, M Sarac, S Coskun & C Jale

  2. Biochemistry Department, Uludag University Medical School, Bursa, Turkey

    Z Serdar

Authors
  1. D Yesilbursa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Z Serdar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Serdar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Sarac
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Coskun
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C Jale
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D Yesilbursa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yesilbursa, D., Serdar, Z., Serdar, A. et al. Lipid peroxides in obese patients and effects of weight loss with orlistat on lipid peroxides levels. Int J Obes 29, 142–145 (2005). https://doi.org/10.1038/sj.ijo.0802794

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0802794

Keywords

This article is cited by

Search

Advanced search

Quick links